Vice President of Clinical Development for Ophthalmology

Vice President of Clinical Development for Ophthalmology About the Company Innovative company designing and developing gene therapeutic products in the biotechnology industry. Company Overview Founded in 2013, our public biotechnology company focuses on groundbreaking gene therapies that target rare diseases. With a dedicated team of 51-200 employees, we are committed to advancing healthcare through innovative solutions. Role Overview We are looking for a dynamic and experienced Vice President of Clinical Development to spearhead our global efforts in developing ophthalmic genetic medicines. In this influential role, you will lead the charge in introducing the first intravitreally delivered genetic treatments aimed at reversing irreversible blindness. Your leadership will be vital in overseeing clinical studies, ensuring patient safety, maintaining data integrity, and enforcing adherence to protocols. Key Responsibilities Design, execute, and monitor clinical trials for ophthalmic gene therapies. Prepare critical clinical documents for regulatory submissions. Ensure the safety and well-being of trial participants. Collaborate with internal teams and external partners to drive clinical development. Represent the company in discussions with potential partners and stakeholders in the ophthalmic and biotech sectors. Candidate Profile The ideal candidate will possess: An M.D. degree with clinical training in ophthalmology. A minimum of 10 years in the biopharma industry focused on drug development, particularly with Phase 3 experience in retinal diseases. A proven history of leading and executing successful clinical trials. Experience with global regulatory interactions and submissions (NDA, BLA, or MAA). A solid understanding of the ophthalmic competitive landscape, especially related to retinal diseases. We are looking for a strategic thinker with excellent leadership and communication skills who can thrive in a fast-paced, matrixed environment. If you are passionate about advancing clinical development in ophthalmology and have the expertise we need, we would love to hear from you. Travel Requirement Approximately 20% travel. Reporting to Chief Medical Officer.